Moderator: Allen L. Carl, MD
Spine treatment technology has experienced major advances over the past 30 years. Due to the maturation of the discipline, there is more evolutionary development than there are revolutionary advances. Societal changes and communication methodology changes make for the potential of a major disruptive paradigm shift in the future of product development. An understanding of how to proceed and implement your ideas, for the betterment of your patients, will become necessary to a greater degree than ever before. This session will educate the caregiver on the steps to developing technology that they see may be helpful through their daily dealings with patient care. It also presents traditional and more innovative pathways for future technology development. Participants will learn the perspectives of venture capitalists when they examine new ideas and see how regulators unintentionally hinder product acceptance and development.
Upon completion of this session, participants will gain strategies to:
- Recognize the options available to develop innovative spine technology
- Educate participants in the steps of innovation development
- Learn how venture capitalists view new products
- Appreciate the fundamental differences between product approval and insurance reimbursement
- Gain knowledge about how to optimize arrangements with employers and co-developers
Agenda
Facilitating Innovation through Peer Collaboration, Evaluation and Investment
Allen L. Carl, MD
Connecting Medical Startups with Physicians, Investors, and Industry
Mark Mescher
How the Money Works: Funding and Exit Strategies (Investor Relations)
Marek Ciszeski, JD
Dealing with Academics or Co-Developers
Michael H. Heggeness, MD, PhD
Navigating Product Approvals and Reimbursement
Eric J. Muehlbauer, MJ, CAE
Faculty Panel Discussion, Questions and Answers